H.T. Ford

4.5k citations
78 papers · 3.7k · h-index 34

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies
    • Cancer Cells and Metastasis

Papers in

    • Cancer Treatment and Pharmacology 13
    • Lung Cancer Research Studies 8
    • Cancer Diagnosis and Treatment 7
    • Bone health and treatments 6
    • Breast Cancer Treatment Studies 14

H.T. Ford

77 papers receiving 3.4k citations

Peers

H.T. Ford
Comparison fields: 5 of 125
  • Cancer Research 1.1k
  • Oncology 1.5k
  • Pathology and Forensic Medicine 627
  • Pulmonary and Respiratory Medicine 728
  • Genetics 545
Replace G.H. Blijham with:
G.H. Blijham Netherlands
S. Ashley United Kingdom
Peter D. Eisenberg United States
Christos Markopoulos Greece
Matti Eskelinen Finland
Byung Ho Son South Korea
Shigemitsu Takashima Japan
Jean Latreille Canada
Hans-Jörg Senn Switzerland
Sei Hyun Ahn South Korea
H.T. Ford relative to G.H. Blijham Netherlands G.H. Blijham's profile →
Citations per field
00.5×1.5×2.0×
G.H. Blijham · 1×
Citations per year

Countries citing papers authored by H.T. Ford

Since Specialization
Citations

This map shows the geographic impact of H.T. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.T. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.T. Ford more than expected).

Fields of papers citing papers by H.T. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.T. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.T. Ford. The network helps show where H.T. Ford may publish in the future.

Co-authors

The 25 scholars most cited alongside H.T. Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H.T. Ford Line = papers co-authored together H.T. Ford links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998274
2 1994224
3 1991179
4 1987169
5
Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.
1994140
6 1981137
7 1988132
8 1981130
9 1996127
10 1980119
11 1980109
12 199099
13 199197
14 199695
15 198393
16 198785
17 198385
18 197877
19 197873
20 198771

About H.T. Ford

H.T. Ford is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 78 papers that have together received 3.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (13 papers), Estrogen and related hormone effects (10 papers), Breast Lesions and Carcinomas (10 papers), Lung Cancer Research Studies (8 papers), Cancer Diagnosis and Treatment (7 papers), Bone health and treatments (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.5k citations), Pathology and Forensic Medicine (627 citations), Pulmonary and Respiratory Medicine (728 citations) and Genetics (545 citations). H.T. Ford has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include J.-C. Gazet, R. Charles Coombes, T.J. Powles, Ian E. Smith, A G Nash, Clive Harmer, J C Gazet, S. Ashley, Tamas Hickish and Peter Hoskin. Their work appears in journals such as The Lancet, Clinical Oncology, Cancer, Cancer Chemotherapy and Pharmacology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact